{"prompt": "['Interferon beta-la', 'MESTRE-MS Study', \"EMR200136_59'\", '15', 'Annexes', 'None', 'CONFIDENTIAL', '56/60', 'INFORMATION', 'M']['Interferon beta-la', 'MESTRE-MS Study', 'EMR200136_597', '15.1', 'Signature pages and responsible persons for the study', 'CONFIDENTIAL', '57/60', 'INFORMATION', 'M']['Interferon beta-la', 'MESTRE-MS Study', 'EMR200136_597', 'Signature Page - Protocol Lead', 'Study Title:', 'A Phase IV, prospective, multicenter, open label,', 'uncontrolled, non-interventional, single arm study to', 'measure treatment satisfaction of multiple sclerosis', '(MS) patients on Rebif after discontinuing initial', 'first-line treatment', 'Study Protocol Date / Version:', '10 Oct 2016 / Version 2.0', 'Protocol Lead responsible for designing the non-interventional study:', 'I approve the design of PPD', 'study protocol:', 'PPD', 'Signature', 'Date of Signature', 'PPD', 'Name, academic degree:', 'PPD', 'Function / Title:', 'Institution:', 'Merk B.V.,', 'Address:', 'Tupolevlaan 41-61,', '1119 NW Schiphol-Rijk,', 'The Netherlands.', 'PPD', 'Telephone number:', 'PPD', 'Fax number:', 'E-mail address:', 'PPD', 'CONFIDENTIAL', '58/60', 'INFORMATION', 'M']\n\n###\n\n", "completion": "END"}